Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286988 · ClinicalTrials.gov registry record · Phase 4
Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children
A Phase 4 study, sponsored by Monarch Medical Research.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00286988 is a Phase 4 study that was terminated before completion, run by Monarch Medical Research. The registered enrollment target is 12 participants.
The verdict
NCT00286988, a Phase 4 study, was terminated before completion, sponsored by Monarch Medical Research.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness, tolerability and safety of oral topiramate for the preventative management of Cyclic Vomiting Syndrome. It is believed that topiramate will decrease the frequency, duration and severity of attacks experienced by children and adolescents with Cyclic Vomiting Syndrome.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00286988
The ClinicalTrials.gov registry entry for NCT00286988 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monarch Medical Research, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00286988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00286988 about?
NCT00286988 is a clinical study titled "Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children". The purpose of this study is to assess the effectiveness, tolerability and safety of oral topiramate for the preventative management of Cyclic Vomiting Syndrome. It is believed that topiramate will decrease the frequency, duration and severity of attacks experienced by children and adolescents with ...
What is the current status of trial NCT00286988?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2006-03. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00286988?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00286988?
This trial is sponsored by Monarch Medical Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.